| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |